A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth

References

• Woglom WH. Immunity to transplantable tumours. Cancer Rev 1929; 4:129 - 214
   Google Scholar
• Goldie JH, Coldman AJ. A model for tumor response to chemotherapy: an integration of the stem cell and somatic mutation hypotheses. Cancer Invest 1985; 3:553 - 64; http://dx.doi.org/10.3109/07357908509039817; PMID: 3910195
   PubMed Web of Science ®Google Scholar
• Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms: Part I. J Surg Oncol 1995; 60:137 - 46; http://dx.doi.org/10.1002/jso.2930600216; PMID: 7564383
   PubMed Web of Science ®Google Scholar
• Schreiber K, Rowley DA, Riethmuller G, Schreiber H. Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments. Hematol Oncol Clin North Am 2006; 20:567 - 84; http://dx.doi.org/10.1016/j.hoc.2006.03.001; PMID: 16762725
   PubMed Web of Science ®Google Scholar
• Weiss DW. Animal models of cancer immunotherapy: questions of relevance. Cancer Treat Rep 1980; 64:481 - 5; PMID: 7407787
   PubMedGoogle Scholar
• Buckwalter MR, Srivastava PK. “It is the antigen(s), stupid” and other lessons from over a decade of vaccitherapy of human cancer. Semin Immunol 2008; 20:296 - 300; http://dx.doi.org/10.1016/j.smim.2008.07.003; PMID: 18715801
   PubMed Web of Science ®Google Scholar
• Akazawa T, Inoue N, Shime H, Kodama K, Matsumoto M, Seya T. Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion. Cancer Sci 2010; 101:1596 - 603; http://dx.doi.org/10.1111/j.1349-7006.2010.01583.x; PMID: 20507323
   PubMed Web of Science ®Google Scholar
• Buhé V, Pers JO, Marianowski R, Berthou C, Youinou P, Loisel S. Development of a Murine model to dissect the CpG-oligonucleotide-enhancement of the killing of human B Cells by rituximab. J Autoimmun 2010; 34:136 - 44; http://dx.doi.org/10.1016/j.jaut.2009.08.007; PMID: 19726161
   PubMed Web of Science ®Google Scholar
• Garcia-Hernandez ML, Hamada H, Reome JB, Misra SK, Tighe MP, Dutton RW. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. J Immunol 2010; 184:4215 - 27; http://dx.doi.org/10.4049/jimmunol.0902995; PMID: 20237297
   PubMed Web of Science ®Google Scholar
• Harnack U, Johnen H, Pecher G. IL-1 receptor antagonist anakinra enhances tumour growth inhibition in mice receiving peptide vaccination and beta-(1-3),(1-6)-D-glucan. Anticancer Res 2010; 30:3959 - 65; PMID: 21036709
   PubMed Web of Science ®Google Scholar
• Kayashima H, Toshima T, Okano S, Taketomi A, Harada N, Yamashita Y, et al. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice. J Immunol 2010; 185:698 - 708; http://dx.doi.org/10.4049/jimmunol.0900187; PMID: 20498356
   PubMed Web of Science ®Google Scholar
• Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, et al. Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Res 2010; 70:6725 - 34; http://dx.doi.org/10.1158/0008-5472.CAN-10-0735; PMID: 20647327
   PubMed Web of Science ®Google Scholar
• Paulos CM, Carpenito C, Plesa G, Suhoski MM, Varela-Rohena A, Golovina TN, et al. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci Transl Med 2010; 2:55ra78; http://dx.doi.org/10.1126/scitranslmed.3000448; PMID: 20980695
   PubMed Web of Science ®Google Scholar
• Ringshausen I, Feuerstacke Y, Krainz P, den Hollander J, Hermann K, Buck A, et al. Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts. Cancer Res 2010; 70:4292 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-10-0259; PMID: 20460536
   PubMed Web of Science ®Google Scholar
• Sharkey RM, Karacay H, Goldenberg DM. Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides. Cancer 2010; 116:1134 - 45; http://dx.doi.org/10.1002/cncr.24802; PMID: 20127947
   PubMed Web of Science ®Google Scholar
• Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA. Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res 2010; 70:6171 - 80; http://dx.doi.org/10.1158/0008-5472.CAN-10-0153; PMID: 20631075
   PubMed Web of Science ®Google Scholar
• Xie Y, Akpinarli A, Maris C, Hipkiss EL, Lane M, Kwon EK, et al. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med 2010; 207:651 - 67; http://dx.doi.org/10.1084/jem.20091921; PMID: 20156973
   PubMed Web of Science ®Google Scholar
• Zhao Y, Moon E, Carpenito C, Paulos CM, Liu X, Brennan AL, et al. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res 2010; 70:9053 - 61; http://dx.doi.org/10.1158/0008-5472.CAN-10-2880; PMID: 20926399
   PubMed Web of Science ®Google Scholar
• Maletzki C, Gock M, Klier U, Klar E, Linnebacher M. Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol 2010; 16:3546 - 52; http://dx.doi.org/10.3748/wjg.v16.i28.3546; PMID: 20653063
   PubMed Web of Science ®Google Scholar
• Srivastava PK. Immunotherapy of human cancer: lessons from mice. Nat Immunol 2000; 1:363 - 6; http://dx.doi.org/10.1038/80795; PMID: 11062489
   PubMed Web of Science ®Google Scholar
• Finkelstein SE, Heimann DM, Klebanoff CA, Antony PA, Gattinoni L, Hinrichs CS, et al. Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J Leukoc Biol 2004; 76:333 - 7; http://dx.doi.org/10.1189/jlb.0304120; PMID: 15155774
   PubMed Web of Science ®Google Scholar
• Winn HJ. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol 1961; 86:228 - 39; PMID: 13785862
   PubMed Web of Science ®Google Scholar
• Skipper HE. Cancer chemotherapy is many things: G.H.A. Clowes Memorial Lecture. Cancer Res 1971; 31:1173 - 80; PMID: 5115048
   PubMed Web of Science ®Google Scholar
• Dethlefsen LA, Prewitt JM, Mendelsohn ML. Analysis of tumor growth curves. J Natl Cancer Inst 1968; 40:389 - 405; PMID: 5638610
   PubMed Web of Science ®Google Scholar
• Budach W, Taghian A, Freeman J, Gioioso D, Suit HD. Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst 1993; 85:988 - 93; http://dx.doi.org/10.1093/jnci/85.12.988; PMID: 8496984
   PubMed Web of Science ®Google Scholar
• Rockwell SC, Kallman RF, Fajardo LF. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst 1972; 49:735 - 49; PMID: 4647494
   PubMed Web of Science ®Google Scholar